Bharat Biotech Initiates Clinical Trials For TB Vaccine ‘MTBVAC’ On Adults In India
24 Mar 2024 19:32 PM IST
Bharat Biotech International Ltd announced the commencement of clinical trials for the Tuberculosis vaccine MTBVAC on adults in India, marking a significant milestone in the fight against TB. Developed by the Spanish biopharmaceutical company Biofabri, MTBVAC represents the first vaccine against Tuberculosis derived from a human source. Conducted in close collaboration with Biofabri, Bharat Biotech […]